此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

验证Dozee用于无接触监测心率、呼吸和活动的有效性

2026年9月16日 更新者:Turtle Shell Technologies Pvt. Ltd.

Dozee系统无接触监测心率、呼吸频率、活动及离床的临床验证

The Dozee VS system (K221555) is a contactless device that tracks heart rate and breathing rate using a sensor sheet placed under the mattress. It captures body vibrations and converts them into vital signs, which can be monitored remotely in real time. The system also supports add-ons like a blood pressure cuff, pulse oximeter, and thermometer, offering a complete monitoring solution. This study aims to validate the updated AI-powered heart rate and improved breathing rate algorithms across different sensor sheet types to confirm clinical accuracy

研究概览

详细说明

The Dozee VS system (K221555), developed by Turtle Shell Technologies, is a non-invasive, contactless device that continuously monitors heart rate (HR) and breathing rate (RR). A thin sensor sheet placed under the mattress detects tiny body vibrations from the heart and lungs, which are processed by smart algorithms and displayed on a secure online dashboard for real-time monitoring.

Unlike traditional methods such as ECGs, nasal tubes, or thermistors-which are invasive, require skilled placement, and are uncomfortable for long-term use-Dozee is simple, comfortable, and doesn't rely on patient compliance like wearables do. The system can also connect to add-on devices, including a blood pressure cuff, pulse oximeter, and thermometer, giving a full picture of a patient's vital signs and helping spot early signs of deterioration.

Hardware upgrades now include dual-sensor sheets that improve accuracy across different mattresses and patient types. The new HR algorithm uses AI/ML for better accuracy, while the improved RR algorithm performs more reliably even with movement or weak signals.

Study Goal: This study aims to validate the updated algorithms (Gen 2) for HR and RR across the three sensor sheet types (DS, S1, and S1-I) to ensure they meet clinical accuracy standards and to benchmark against the previous versions of the algorithms

研究类型

观察性的

注册 (实际的)

91

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Texas
      • Midland、Texas、美国、79707
        • ERA Health Research

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 100年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

概率样本

研究人群

The study will be conducted on atleast 60 subjects in the age group above 18 years regardless of gender. The patients/volunteers be informed about the study and a written informed consent form will be obtained from them. Dozee will be placed under the mattress of the patient's bed and the data will be collected through the device whenever a patient is on the bed.

描述

Inclusion Criteria:

Subjects will be included if they meet the following inclusion criteria:

  1. Adults Male or female. (Above 18 years of age)
  2. Provide written informed consent.
  3. Weight between 40kg/88.18lbs and 120kg/264.55lbs
  4. Agree to not eat during the testing period
  5. Able to move and exit the bed independently and safely.

Exclusion Criteria:

Subjects will be excluded if they have any of the following inclusion criteria:

  1. Are connected to a device that may interfere with the device monitoring in this study.
  2. Are receiving any bedside care which may be incompatible with the study procedures.
  3. A likely need to receive or undergo a procedure during the testing period.
  4. Cannot accept a nasal cannula, or have an ECG leads placed on the chest.
  5. Have a significant medical condition in the judgement of the investigator, which may compromise the study testing procedures.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Single Arm Study (Cohort)

Group/Cohort Description: All participants will be on standard telemetry monitoring for Heart Rate and Respiration Rate using the gold standard (Electrocardiography and Capnography respectively). In addition, a contactless monitoring devices will be placed on the patient bed to measure data. This device is Dozee VS (Investigational Device). Data from all devices will be measured simultaneously.

All participants will be on standard telemetry monitoring for Heart Rate, Respiration Rate and movements using the gold standard (Electrocardiography and Capnography respectively).

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Mean Absolute Error (MAE) of Dozee's Heart Rate a from the Gold Standard ECG
大体时间:6 months

Heart Rate collected at 1 Min intervals from gold standard and Dozee. Mean Absolute Error (MAE) of the Dozee Heart Rate will be calculated.

6 months
Accuracy (%) of Dozee in identfying subject movement
大体时间:6 months

Time stamps of subject movement during the study will be recorded manullay. Time stamps of Dozee's movement will be recorded. Accuracy of the Dozee device in detecting movement compared to manual observation will be computed in terms of percentage.

6 months
Accuracy(%) of of Dozee's bed-exits
大体时间:6 months

Time stamps of bed-exits will be recorded manually during the study will be recorded. Time stamps of Dozee's bed-exit will be computed. Accuracy of the Dozee device in detecting bed-exit compared to manual observation as gold standard will be computed in terms of percentage.

6 months
Mean Absolute Error (MAE) of Dozee's Respiratory Rate from the Gold Standard Capnography
大体时间:6 Months

Respiratory Rate collected at 1 Min intervals from gold standard and Dozee. Mean Absolute Error (MAE) of the Dozee Respiratory Rate will be calculated.

6 Months

次要结果测量

结果测量
措施说明
大体时间
Range of values (minimum, maximum, and spread) of Heart Rate in beats per min measured by the gold standard and the Dozee
大体时间:6 months

The outcome will be assessed by comparing the range of values (minimum, maximum, and spread) of Heart Rate ( beats per minute) measured by the gold standard and the Dozee over the study period.

6 months
Range of values (minimum, maximum, and spread) of Respiratory Rate in breaths per min measured by the gold standard and the Dozee
大体时间:6 Months

The outcome will be assessed by comparing the range of values (minimum, maximum, and spread) of Respiratory Rate ( breaths per minute) measured by the gold standard and the Dozee over the study period.

6 Months
Bland- Altman Level of Agreement between Dozee Heart Rate and Respiratory Rate with the Gold Standard
大体时间:6 months

Level of Agreement between Dozee's HR and RR with reference device computed by Bland Altman.

6 months
Detection rate (%) of the Dozee's Heart Rate and Respiratory Rate
大体时间:6 months

The time-stamps of Dozee's Heart Rate and Respiratory Rate and the gold standard Heart Rate and Respiratory Rate will be recorded. DR is the proportion of gold standard points for which the DS successfully provides a corresponding measured value, relative to the total number of gold standard points.

6 months
Level of Agreement between Dozee Heart Rate and Respiratory Rate with the Gold Standard
大体时间:6 months

Level of Agreement between Dozee Heart Rate and Respiratory Rate with the Gold Standard by using Deming Regression with Pearson Co-efficient

6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Sapna Chilka, MD、ERA Health Research

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年9月16日

初级完成 (实际的)

2025年11月25日

研究完成 (实际的)

2025年12月18日

研究注册日期

首次提交

2025年9月23日

首先提交符合 QC 标准的

2025年10月30日

首次发布 (实际的)

2025年11月3日

研究记录更新

最后更新发布 (实际的)

2026年9月21日

上次提交的符合 QC 标准的更新

2026年9月16日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • DZ_VS_VAL

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual Participant Data (IPD) are protected under HIPPA Act of 1996.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅